Home/Biophytis/Waly Dioh
WD

Waly Dioh

Chief Operating Officer

Biophytis

Biophytis Pipeline

DrugIndicationPhase
BIO101 (20-hydroxyecdysone)SarcopeniaPhase 3
MASSIVE Project CandidatesSarcopenia (Next-generation)Discovery
AI Platform CandidatesDry Age-Related Macular Degeneration (AMD)Discovery